药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Armodafinil
The metabolism of Trastuzumab emtansine can be increased when combined with Armodafinil.
Econazole
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Trastuzumab emtansine.
Econazole
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Trastuzumab emtansine.
Econazole
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Trastuzumab emtansine.
Econazole
Roflumilast
Roflumilast may increase the immunosuppressive activities of Trastuzumab emtansine.
Econazole
Bleselumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bleselumab.
Econazole
Rozanolixizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Rozanolixizumab.
Econazole
Risankizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Risankizumab.
Econazole
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Monomethyl fumarate.
Econazole
Tetrandrine
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tetrandrine.
Econazole
Fluclorolone
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fluclorolone.
Econazole
Fluperolone
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fluperolone.
Econazole
Begelomab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Begelomab.
Econazole
Fluocortin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Fluocortin.
Econazole
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Econazole
Hypericin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Hypericin.
Econazole
Acteoside
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Acteoside.
Econazole
Deoxyspergualin
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Deoxyspergualin.
Econazole
Doxifluridine
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Doxifluridine.
Econazole
Trofosfamide
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Trofosfamide.